Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Braun AE, Chan JM, Neuhaus J, Cowan JE, Kenfield SA, Van Blarigan EL, Tenggara I, Broering JM, Simko JP, Carroll PR, Cooperberg MR. The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer. Cancer. 2024 May 15;130(10):1766-1772. doi: 10.1002/cncr.35215. Epub 2024 Jan 27. PubMed PMID: 38280206.
Colley A, Broering J, Lee K, Lin JA, Pierce L, Finlayson E, Sudore RL, Wick EC. "It Gives Me Peace of Mind So I Can Focus on Healing": Views on Advance Care Planning for Older Surgical Patients. J Palliat Med. 2024 Feb 20;. doi: 10.1089/jpm.2023.0589. [Epub ahead of print] PubMed PMID: 38386513.
Nosrat C, Martin-Tuite P, Jiang F, Broering J, Shindel AW. Gender Bias in Letters of Recommendation: Relevance to Urology Match Outcomes and Pursuit of Fellowship Training/Academic Career. Urology. 2024 Jan;183:281-287. doi: 10.1016/j.urology.2023.09.053. Epub 2023 Nov 7. PubMed PMID: 37940078.
Herlemann A, Cowan JE, Washington SL 3rd, Wong AC, Broering JM, Carroll PR, Cooperberg MR. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. 2023 Oct 17;. doi: 10.1016/j.eururo.2023.09.024. [Epub ahead of print] PubMed PMID: 37858454.
Baskin A, Cowan JE, Braun A, Lonergan PE, Mohamad O, Washington SL 3rd, Zhao S, Broering JM, Cooperberg MR, Breyer BN, Carroll PR. Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer. Urol Oncol. 2023 Oct;41(10):429.e9-429.e14. doi: 10.1016/j.urolonc.2023.06.003. Epub 2023 Jul 3. PubMed PMID: 37407420.
Washington SL 3rd, Lonergan PE, Cowan JE, Zhao S, Broering JM, Palmer NR, Hicks C, Cooperberg MR, Carroll PR. Ten-year work burden after prostate cancer treatment. Cancer Med. 2023 Sep;12(18):19234-19244. doi: 10.1002/cam4.6530. Epub 2023 Sep 19. PubMed PMID: 37724617; PubMed Central PMCID: PMC10557888.
Lonergan PE, Baskin A, Greenberg SA, Mohamad O, Washington SL 3rd, Zhao S, Cowan JE, Broering JM, Nguyen HG, Cooperberg MR, Breyer BN, Carroll PR. The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer. Urology. 2023 Aug;178:114-119. doi: 10.1016/j.urology.2023.05.012. Epub 2023 May 25. PubMed PMID: 37244430.
Langlais CS, Graff RE, Van Blarigan EL, Neuhaus JM, Cowan JE, Broering JM, Carroll P, Kenfield SA, Chan JM. Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality. Br J Cancer. 2023 Aug;129(2):346-355. doi: 10.1038/s41416-023-02283-1. Epub 2023 May 22. PubMed PMID: 37217583; PubMed Central PMCID: PMC10338438.
Belkora JK, Broering JM, Neuhaus J, Zargham A, Weinberg T, Witte JS, Kenfield SA, Van Blarigan EL, Cooperberg MR, Carroll PR, Chan JM. Controlled trial of decision support for men with early-stage prostate cancer: brief research report of effects on patient knowledge. Front. Urol.. 2023 May; 3:1127089. doi: 10.3389/fruro.2023.1127089.
Smith LH, García-Albéniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernán MA. Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula. Eur J Epidemiol. 2022 Dec;37(12):1205-1213. doi: 10.1007/s10654-022-00929-7. Epub 2022 Oct 26. PubMed PMID: 36289138.
Weng X, Zhong L, Xiang P, Li Y, Paciorek A, Dong L, Broering J, Carroll PR, Sanda M, Wilson L. Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13740. doi: 10.1111/ecc.13740. Epub 2022 Oct 14. PubMed PMID: 36239065.
Langlais CS, Graff RE, Van Blarigan EL, Kenfield SA, Neuhaus J, Tabung FK, Cowan JE, Broering JM, Carroll P, Chan JM. Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality. Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1760-1768. doi: 10.1158/1055-9965.EPI-22-0147. PubMed PMID: 35767977; PubMed Central PMCID: PMC9444922.
Bongiovanni T, Lancaster E, Decket H, Mukhtar RK, Schwab M, Broering J, O"Sullivan P, Hirose K, Wick E. See one, do one, teach one: a flipped classroom to make quality improvement experiential in surgical residency. Global Surgical Education - Journal of the Association for Surgical Education. 2022 August; 1(1):36.
Lonergan PE, Washington SL 3rd, Cowan JE, Zhao S, Broering JM, Cooperberg MR, Carroll PR. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. J Urol. 2022 Apr;207(4):832-840. doi: 10.1097/JU.0000000000002335. Epub 2021 Dec 2. PubMed PMID: 34854749.
Johnson C, Colley A, Broering JM, Bongiovanni T, Roman S, Wick E. Advanced Practice Provider Perspectives on Advanced Care Planning. Journal of Clinical and Translational Science. 2022; 6(S1):75-76. doi: 10.1017/cts.2022.227.
Johnson CL, Schwartz H, Greenberg A, Hernandez S, Nnamani Silva ON, Wong LE, Martins DB, Broering JM, Kumar SB, Bongiovanni T, Wick EC, Roman SA. Patient Perceptions on Barriers and Facilitators to Accessing Low-acuity Surgery During COVID-19 Pandemic. J Surg Res. 2021 Aug;264:30-36. doi: 10.1016/j.jss.2021.01.028. Epub 2021 Feb 6. PubMed PMID: 33744775; PubMed Central PMCID: PMC7867400.
Langlais CS, Chan JM, Kenfield SA, Cowan JE, Graff RE, Broering JM, Carroll P, Van Blarigan EL. Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history. Cancer Causes Control. 2021 Jun;32(6):635-644. doi: 10.1007/s10552-021-01417-1. Epub 2021 Apr 9. PubMed PMID: 33837499; PubMed Central PMCID: PMC8189293.
Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM. Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial. J Med Internet Res. 2020 Dec 31;22(12):e19238. doi: 10.2196/19238. PubMed PMID: 33382378; PubMed Central PMCID: PMC7808895.
Wang EY, Graff RE, Chan JM, Langlais CS, Broering JM, Ramsdill JW, Kessler ER, Winters-Stone KM, Van Blarigan EL, Kenfield SA. Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study. JMIR Cancer. 2020 Nov 10;6(2):e19362. doi: 10.2196/19362. PubMed PMID: 33170126; PubMed Central PMCID: PMC7685923.
Borno HT, Cowan JE, Zhao S, Broering JM, Carroll PR, Ryan CJ. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry. Urol Oncol. 2020 Oct;38(10):793.e1-793.e11. doi: 10.1016/j.urolonc.2020.07.012. Epub 2020 Aug 8. PubMed PMID: 32782182.
Jeong CW, Herlemann A, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR. The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer. JNCI Cancer Spectr. 2020 Oct;4(5):pkaa044. doi: 10.1093/jncics/pkaa044. eCollection 2020 Oct. PubMed PMID: 33134826; PubMed Central PMCID: PMC7583149.
Wang E, Graff R, Chan J, Langlais C, Broering J, Ramsdill J, Kessler E, Winters-Stone K, Van Blarigan E, Kenfield S. Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study (Preprint). [preprint]. 2020 April. doi: 10.2196/preprints.19362.
Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry. Clin Genitourin Cancer. 2020 Feb;18(1):e21-e27. doi: 10.1016/j.clgc.2019.10.026. Epub 2019 Nov 6. PubMed PMID: 31796344.
Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients. Cancer Med. 2020 Jan;9(1):125-132. doi: 10.1002/cam4.2685. Epub 2019 Nov 12. PubMed PMID: 31714037; PubMed Central PMCID: PMC6943165.
Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry. Eur Urol. 2019 Dec;76(6):743-751. doi: 10.1016/j.eururo.2019.07.012. Epub 2019 Jul 23. PubMed PMID: 31345635.
Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM. Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy. Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1917-1925. doi: 10.1158/1055-9965.EPI-19-0488. Epub 2019 Aug 28. PubMed PMID: 31462398; PubMed Central PMCID: PMC6825577.
Kata A, Dutt M, Sudore RL, Finlayson E, Broering JM, Tang VL. What Matters? The Valued Life Activities of Older Adults Undergoing Elective Surgery. J Am Geriatr Soc. 2019 Nov;67(11):2305-2310. doi: 10.1111/jgs.16102. Epub 2019 Aug 10. PubMed PMID: 31400227; PubMed Central PMCID: PMC6910083.
Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer. J Urol. 2019 Oct;202(4):689-695. doi: 10.1097/JU.0000000000000336. Epub 2019 Sep 6. PubMed PMID: 31091175; PubMed Central PMCID: PMC7017721.
Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR. Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 2019 Sep;131:157-165. doi: 10.1016/j.urology.2019.05.018. Epub 2019 May 28. PubMed PMID: 31150694.
Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):117-124. doi: 10.1038/s41391-018-0084-3. Epub 2018 Aug 31. PubMed PMID: 30171230.
Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM. Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Nov 15;7(11):e11257. doi: 10.2196/11257. PubMed PMID: 30442638; PubMed Central PMCID: PMC6265599.
Kata A, Sudore R, Finlayson E, Broering JM, Ngo S, Tang VL. Increasing Advance Care Planning Using a Surgical Optimization Program for Older Adults. J Am Geriatr Soc. 2018 Oct;66(10):2017-2021. doi: 10.1111/jgs.15554. Epub 2018 Oct 5. PubMed PMID: 30289968; PubMed Central PMCID: PMC6181775.
Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™). Prostate. 2018 Jan;78(1):32-39. doi: 10.1002/pros.23441. Epub 2017 Nov 6. PubMed PMID: 29105845; PubMed Central PMCID: PMC5716878.
Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR. Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments. J Urol. 2017 Sep;198(3):671-677. doi: 10.1016/j.juro.2017.03.121. Epub 2017 Mar 22. PubMed PMID: 28342935; PubMed Central PMCID: PMC5636214.
Hussein AA, Welty CJ, Broering JM, Cooperberg MR, Carroll PR. National Prostate Cancer Registries: Contemporary Trends of Prostate Cancer in the United States. Urology Practice. 2014 November; 1(4):198-204. doi: 10.1016/j.urpr.2014.07.005.
Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P. Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test. Value Health. 2014 Nov;17(7):A651. doi: 10.1016/j.jval.2014.08.2366. Epub 2014 Oct 26. PubMed PMID: 27202352.
Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments. Qual Life Res. 2014 Mar;23(2):495-508. doi: 10.1007/s11136-013-0493-7. Epub 2013 Aug 13. PubMed PMID: 23943258.
Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C. - Data quality with mixed-mode administration of the short form-36. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research. 2014; 17(3):A198.
Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. 2010 Nov 15;116(22):5226-34. doi: 10.1002/cncr.25456. PubMed PMID: 20690197; PubMed Central PMCID: PMC2975879.
Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010 Mar;91(3):712-21. doi: 10.3945/ajcn.2009.28474. Epub 2009 Dec 30. PubMed PMID: 20042525; PubMed Central PMCID: PMC3132069.
Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1. PubMed PMID: 20124165; PubMed Central PMCID: PMC2834465.
Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol. 2009 Sep 10;27(26):4306-13. doi: 10.1200/JCO.2008.21.5228. Epub 2009 Aug 10. PubMed PMID: 19667269; PubMed Central PMCID: PMC2744272.
Cooperberg MR, Broering JM, Carroll PR. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009 Jun 16;101(12):878-87. doi: 10.1093/jnci/djp122. Epub 2009 Jun 9. PubMed PMID: 19509351; PubMed Central PMCID: PMC2697208.
Cooperberg MR, Cowan J, Broering JM, Carroll PR. High-risk prostate cancer in the United States, 1990-2007. World J Urol. 2008 Jun;26(3):211-8. doi: 10.1007/s00345-008-0250-7. Epub 2008 Mar 28. PubMed PMID: 18369637; PubMed Central PMCID: PMC2948572.
Wilson L, Liang SY, Kwon P, Sadetsky N, Greene KL, Broering JM, Carroll PR. Longitudinal comparison across treatments, risk and age of work loss costs in prostate cancer patients: 10-year patterns. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2008; 11(3):A68-9. doi: 10.1016/S1098-3015(10)70226-6.
Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007 Sep;178(3 Pt 2):S14-9. doi: 10.1016/j.juro.2007.03.135. Epub 2007 Jul 20. PubMed PMID: 17644125; PubMed Central PMCID: PMC2987559.
Litwin MS, Greenfield S, Elkin EP, Lubeck DP, Broering JM, Kaplan SH. Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice. Cancer. 2007 May 1;109(9):1777-83. doi: 10.1002/cncr.22615. PubMed PMID: 17354226.
Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR. Cumulative cost pattern comparison of prostate cancer treatments. Cancer. 2007 Feb 1;109(3):518-27. doi: 10.1002/cncr.22433. PubMed PMID: 17186528.
Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol. 2006 Apr;175(4):1326-31. doi: 10.1016/S0022-5347(05)00647-6. PubMed PMID: 16515991.
Broering JM, Lessard SC, Marr PL, Elkin EP, Lewis JK, Carroll PR, Duchane J. Validation of an Internet-base Patient Health-Related Quality of Life Questionnaire: Data from CaPSURE. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research. 2006; 9(3):A114.
What would you like to do?